NASDAQ: MARPSMarine Petroleum Trust Stock
$4.67+0.08 (+1.74%)
Updated Nov 30, 2023
MARPS Price
$4.67
Fair Value Price
$5.06
Market Cap
$9.34M
52 Week Low
$4.30
52 Week High
$8.87
P/E
6.77x
P/B
9.55x
P/S
6.4x
PEG
0.58x
Dividend Yield
10.17%
Revenue
$1.65M
Earnings
$1.38M
Gross Margin
100%
Operating Margin
83.41%
Profit Margin
83.4%
Debt to Equity
0
Operating Cash Flow
N/A
Beta
0.64
Next Earnings
N/A
Ex-Dividend
Nov 29, 2023
Next Dividend
Dec 28, 2023
MARPS Overview
Marine Petroleum Trust, together with its subsidiary, Marine Petroleum Corporation, operates as a royalty trust in the United States. As of June 30, 2021, the company had an overriding royalty interest in 55 oil and natural gas leases covering approximately 199,868 gross acres located in the Central and Western areas of the Gulf of Mexico off the coasts of Louisiana and Texas. Marine Petroleum Trust was incorporated in 1956 and is based in Dallas, Texas.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MARPS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MARPS ($4.67) is undervalued by 7.71% relative to our estimate of its Fair Value price of $5.06 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MARPS ($4.67) is not significantly undervalued (7.71%) relative to our estimate of its Fair Value price of $5.06 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MARPS ($4.67) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more MARPS due diligence checks available for Premium users.
Be the first to know about important MARPS news, forecast changes, insider trades & much more!
MARPS News
Valuation
MARPS fair value
Fair Value of MARPS stock based on Discounted Cash Flow (DCF)
Price
$4.67
Fair Value
$5.06
Undervalued by
7.71%
MARPS ($4.67) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MARPS ($4.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MARPS ($4.67) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MARPS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.77x
Industry
-28.34x
Market
29.24x
MARPS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MARPS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MARPS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
9.55x
Industry
2.24x
MARPS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MARPS price to earnings growth (PEG)
For valuing profitable companies with growth potential
MARPS is good value based... subscribe to Premium to read more.
PEG Value Valuation
MARPS's financial health
Profit margin
Revenue
$312.8k
Net Income
$258.3k
Profit Margin
82.6%
MARPS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$978.2k
Liabilities
$0.0
Debt to equity
0
MARPS's short-term assets ($978.18k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MARPS's short-term assets ($978.18k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MARPS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MARPS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
MARPS vs Oil & Gas Midstream Stocks
Marine Petroleum Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.